ER-38925

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameER-38925
Drug Alias NameER-38925
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor alpha
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A